Lowe Wealth Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21K | Sell |
250
-15
| -6% | -$1.24K | 0.01% | 205 |
|
|
2025
Q2 | $21K | Sell |
265
-100
| -27% | -$7.95K | 0.01% | 194 |
|
|
2025
Q1 | $32.8K | Sell |
365
-168
| -32% | -$15.7K | 0.01% | 160 |
|
|
2024
Q4 | $53K | Sell |
533
-100
| -16% | -$10.3K | 0.02% | 129 |
|
|
2024
Q3 | $71.9K | Buy |
633
+101
| +19% | +$12K | 0.03% | 101 |
|
|
2024
Q2 | $65.9K | Sell |
532
-30
| -5% | -$3.86K | 0.03% | 104 |
|
|
2024
Q1 | $74.2K | Sell |
562
-55
| -9% | -$6.78K | 0.03% | 93 |
|
|
2023
Q4 | $67.3K | Sell |
617
-75
| -11% | -$7.79K | 0.03% | 95 |
|
|
2023
Q3 | $71.2K | Sell |
692
-100
| -13% | -$10.8K | 0.04% | 87 |
|
|
2023
Q2 | $91.4K | Sell |
792
-50
| -6% | -$5.68K | 0.05% | 82 |
|
|
2023
Q1 | $89.6K | Sell |
842
-344
| -29% | -$37.1K | 0.05% | 79 |
|
|
2022
Q4 | $132K | Sell |
1,186
-200
| -14% | -$20.4K | 0.07% | 59 |
|
|
2022
Q3 | $119K | Sell |
1,386
-41
| -3% | -$3.66K | 0.07% | 55 |
|
|
2022
Q2 | $130K | Sell |
1,427
-440
| -24% | -$39K | 0.07% | 54 |
|
|
2022
Q1 | $153K | Sell |
1,867
-1,302
| -41% | -$103K | 0.07% | 52 |
|
|
2021
Q4 | $243K | Buy |
3,169
+230
| +8% | +$18.3K | 0.11% | 41 |
|
|
2021
Q3 | $221K | Buy |
2,939
+425
| +17% | +$32.3K | 0.1% | 43 |
|
|
2021
Q2 | $196K | Buy |
2,514
+2,002
| +391% | +$149K | 0.09% | 43 |
|
|
2021
Q1 | $38K | Hold |
512
| – | – | 0.02% | 103 |
|
|
2020
Q4 | $40K | Hold |
512
| – | – | 0.02% | 97 |
|
|
2020
Q3 | $41K | Sell |
512
-315
| -38% | -$24.7K | 0.02% | 87 |
|
|
2020
Q2 | $61K | Sell |
827
-583
| -41% | -$43.9K | 0.04% | 59 |
|
|
2020
Q1 | $103K | Sell |
1,410
-7
| -0.5% | -$550 | 0.07% | 40 |
|
|
2019
Q4 | $123K | Sell |
1,417
-46
| -3% | -$3.78K | 0.07% | 38 |
|
|
2019
Q3 | $118K | Hold |
1,463
| – | – | 0.07% | 37 |
|
|
2019
Q2 | $117K | Buy |
1,463
+157
| +12% | +$12K | 0.07% | 37 |
|
|
2019
Q1 | $103K | Hold |
1,306
| – | – | 0.06% | 41 |
|
|
2018
Q4 | $95K | Sell |
1,306
-81
| -6% | -$5.72K | 0.06% | 40 |
|
|
2018
Q3 | $94K | Sell |
1,387
-128
| -8% | -$8.15K | 0.06% | 43 |
|
|
2018
Q2 | $88K | Hold |
1,515
| – | – | 0.05% | 44 |
|
|
2018
Q1 | $79K | Sell |
1,515
-420
| -22% | -$22.7K | 0.05% | 46 |
|
|
2017
Q4 | $104K | Hold |
1,935
| – | – | 0.06% | 46 |
|
|
2017
Q3 | $118K | Sell |
1,935
-364
| -16% | -$22.1K | 0.07% | 45 |
|
|
2017
Q2 | $141K | Hold |
2,299
| – | – | 0.09% | 38 |
|
|
2017
Q1 | $139K | Hold |
2,299
| – | – | 0.09% | 37 |
|
|
2016
Q4 | $129K | Sell |
2,299
-446
| -16% | -$26.1K | 0.09% | 36 |
|
|
2016
Q3 | $163K | Hold |
2,745
| – | – | 0.11% | 32 |
|
|
2016
Q2 | $151K | Buy |
2,745
+48
| +2% | +$2.56K | 0.1% | 34 |
|
|
2016
Q1 | $136K | Hold |
2,697
| – | – | 0.09% | 36 |
|
|
2015
Q4 | $136K | Hold |
2,697
| – | – | 0.09% | 37 |
|
|
2015
Q3 | $127K | Sell |
2,697
-52
| -2% | -$2.76K | 0.1% | 33 |
|
|
2015
Q2 | $149K | Hold |
2,749
| – | – | 0.1% | 37 |
|
|
2015
Q1 | $151K | Buy |
2,749
+52
| +2% | +$2.94K | 0.1% | 34 |
|
|
2014
Q4 | $146K | Buy |
+2,697
| New | +$150K | 0.1% | 33 |
|
Other funds holding MRK
Lowe Wealth Advisors's MRK Position: Q3 2025 in Review
Lowe Wealth Advisors reduced its Merck (MRK) stake by 5.7% in Q3 2025, selling an estimated $1.24K and leaving 250 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #205.
Lowe Wealth Advisors first reported a position in MRK in Q4 2014 and has held it in 44 quarters since. The position peaked at $243K in Q4 2021. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Lowe Wealth Advisors held 250 shares of Merck worth $21K as of Q3 2025.
- Lowe Wealth Advisors sold 15 Merck shares in Q3 2025, an estimated $1.24K.
- Merck made up 0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #205 holding.
- Lowe Wealth Advisors first reported a position in Merck in Q4 2014 and has held it in 44 quarters since.
- Lowe Wealth Advisors's Merck position peaked at $243K in Q4 2021.
- 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.